Arthritis National Research Foundation Appoints Schalon Newton, DBA, as Principal of Immune Boost Capital
Industry Veteran to Lead New Philanthropic Venture Fund Addressing Critical Early-Stage Funding Gap in Autoimmune Therapeutics and Diagnostics The Arthritis National Research Foundation (ANRF), a leading nonprofit funder of early-stage autoimmune disease research, announced the appointment of Schalon Newton, DBA, as Principal of Immune Boost Capital (IBC), its newly formed philanthropic evergreen venture fund. IBC […]
ANRF at ACR Convergence 2025
Each year, the Arthritis National Research Foundation (ANRF) looks forward to joining the global rheumatology community at ACR Convergence, the American College of Rheumatology’s annual meeting taking place this year October 24–29 in Chicago, Illinois. As the world’s leading rheumatology gathering, ACR Convergence brings together scientists, clinicians, and advocates dedicated to improving lives through research, […]
Arthritis National Research Foundation Launches Immune Boost Capital to Accelerate Early-Stage Autoimmune Innovation
New 501(c)(3) Subsidiary Will Provide Philanthropic Venture Capital for Proof-of-Concept Autoimmune Therapies and Diagnostics The Arthritis National Research Foundation (ANRF), a leading funder of early-stage autoimmune disease research, is proud to announce the formation of Immune Boost Capital (IBC), a wholly owned 501(c)(3) subsidiary created to address a growing gap in therapeutic innovation. IBC is […]
Vie Ventures Convenes Inaugural Therapeutics Advisory Council to Advance Collaboration Among Autoimmune Disease Ecosystems
Vie Ventures welcomes additional strategic collaborators, expanding the coalition to morethan ten leading disease philanthropies focused on autoimmune and inflammatory disease Vie Ventures, a new life sciences investment firm focused on bridging venture capital and disease philanthropy to develop breakthrough therapies for patients, today announced the successful convening of its inaugural Therapeutics Advisory Council (TAC). […]
ANRF Opens 2026–2027 Research Grants, Driving New Solutions for Arthritis and Autoimmune Diseases
From early support to lasting impact, ANRF grants launch the careers of scientists who transform the future of rheumatology. For millions living with arthritis and autoimmune diseases, hope often starts in the lab. On October 1, 2025, the Arthritis National Research Foundation (ANRF) will open applications for its 2026–2027 research grants, providing early-career scientists with […]
Explore the 2025 ANRF Impact Report
Discover the Impact: ANRF’s 2025 Report Is Here The Arthritis National Research Foundation shares its 2025 Impact Report, highlighting the bold science, breakthrough discoveries, and rising researchers shaping the future of arthritis and autoimmune disease treatment. Read the Full 2025 Impact Report Funding the Future of Autoimmune Research With 100% of our funding dedicated to […]
